CD38 and B-cell chronic lymphocytic leukemia: The goal of the present study was to determine whether blood CLL cells co-express CD38 and NGAL-R, and to this end we assessed the levels of CD38 and NGAL-R in CLL cells at the same time point for each patient, as a function of disease severity and treatment.